Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, The University of Auckland, 85 Park Road, Grafton, Auckland 1142, New Zealand
Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, The University of Auckland, 85 Park Road, Grafton, Auckland 1142, New Zealand.
Hum Reprod Update. 2015 Jan-Feb;21(1):97-118. doi: 10.1093/humupd/dmu049. Epub 2014 Sep 15.
Antiphospholipid antibodies (aPL) are a family of auto-antibodies that are associated with an increased risk of recurrent miscarriage, intrauterine growth restriction and preterm birth. The placenta is a major target of aPL and it is likely that these antibodies promote pregnancy morbidity by affecting trophoblast function. Numerous studies have investigated the effect of aPL on trophoblast function in vitro. However, different trophoblast models and a variety of culture conditions have been employed, resulting in a myriad of different reported findings. This review systematically summarized those published studies that have investigated the effect of aPL on trophoblast function in vitro. In addition, the reported effects of pharmacological treatment on trophoblast function in the presence of aPL were also systematically reviewed.
PubMed, Scopus, Embase and Web of Science databases were searched using the keywords 'placenta OR trophoblast' AND 'antiphospholipid antibody OR antiphospholipid syndrome' up to 25 April 2014. Studies were excluded based on the absence of appropriate controls. The effects of aPL on trophoblast proliferation, death, syncytialization, invasion, hormone production, cytokine production, coagulation and complement activation were recorded. The effects of different treatments on the function of trophoblasts in the presence of aPL were also recorded.
A total of 1071 records were retrieved from the four databases. After removing duplicates, the titles and abstracts of 529 articles were reviewed. Of those, 48 articles were read and relevant experimental results were extracted from 47 articles.
This systematic review provides an overview of all the studies performed to date on the effects of aPL on trophoblast function in vitro. There is considerable support for aPL decreasing trophoblast viability, syncytialization and invasion in vitro. Some work has also suggested that aPL may affect the production of hormones and signalling molecules by trophoblasts, and may stimulate coagulation and complement activation in vitro. Current reports of the in vitro effects of therapeutic treatments on trophoblast function in the presence of aPL are inconclusive. This systematic review has highlighted many gaps in our knowledge of how aPL work and may direct future research in this area.
抗磷脂抗体(aPL)是一组自身抗体,与复发性流产、宫内生长受限和早产的风险增加有关。胎盘是 aPL 的主要靶标,这些抗体可能通过影响滋养层功能来促进妊娠发病。许多研究已经在体外研究了 aPL 对滋养层功能的影响。然而,不同的滋养层模型和各种培养条件已经被采用,导致了大量不同的报道结果。本综述系统地总结了那些已经在体外研究了 aPL 对滋养层功能影响的研究。此外,还系统地综述了在存在 aPL 的情况下,药物治疗对滋养层功能的影响。
使用关键词 '胎盘或滋养层' 和 '抗磷脂抗体或抗磷脂综合征' 在 PubMed、Scopus、Embase 和 Web of Science 数据库中进行搜索,检索时间截至 2014 年 4 月 25 日。根据缺乏适当对照,排除了研究。记录了 aPL 对滋养层增殖、死亡、合体化、侵袭、激素产生、细胞因子产生、凝血和补体激活的影响。还记录了不同治疗方法对存在 aPL 时滋养层功能的影响。
从四个数据库中检索到 1071 条记录。在去除重复项后,对 529 篇文章的标题和摘要进行了审查。其中,有 48 篇文章进行了阅读,并从 47 篇文章中提取了相关的实验结果。
本系统综述提供了迄今为止所有关于 aPL 对体外滋养层功能影响的研究概述。有相当多的证据表明 aPL 会降低体外滋养层的活力、合体化和侵袭能力。一些研究还表明,aPL 可能会影响滋养层产生激素和信号分子的能力,并可能刺激体外凝血和补体激活。目前关于治疗方法在存在 aPL 的情况下对滋养层功能的体外影响的报告尚无定论。本系统综述突出了我们对 aPL 作用机制的认识中的许多空白,可能会指导该领域的未来研究。